Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

SOD1 inhibitor ATN-224

(... in-HIH-bih-ter ...)

A substance being studied in the treatment of cancer. It may prevent the growth of new blood vessels that tumors need to grow. SOD1 inhibitor ATN-224 also blocks enzymes that cells need to divide and grow, and it may kill cancer cells. It is a type of antiangiogenesis agent and a type of superoxide dismutase inhibitor. Also called ATN-224.

SOD1 inhibitor ATN-224

Search NCI's Dictionary of Cancer Terms